Literature DB >> 27609404

Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Dorin-Bogdan Borza1.   

Abstract

The glomerular basement membrane (GBM) is an essential component of the glomerular filtration barrier. Heparan sulfate proteoglycans such as agrin are major components of the GBM, along with α345(IV) collagen, laminin-521 and nidogen. A loss of GBM heparan sulfate chains is associated with proteinuria in several glomerular diseases and may contribute to the underlying pathology. As the major determinants of the anionic charge of the GBM, heparan sulfate chains have been thought to impart charge selectivity to the glomerular filtration, a view challenged by the negligible albuminuria in mice that lack heparan sulfate in the GBM. Recent studies provide increasing evidence that heparan sulfate chains modulate local complement activation by recruiting complement regulatory protein factor H, the major inhibitor of the alternative pathway in plasma. Factor H selectively inactivates C3b bound to surfaces bearing host-specific polyanions such as heparan sulfate, thus limiting complement activation on self surfaces such as the GBM, which are not protected by cell-bound complement regulators. We discuss mechanisms whereby the acquired loss of GBM heparan sulfate can impair the local regulation of the alternative pathway, exacerbating complement activation and glomerular injury in immune-mediated kidney diseases such as membranous nephropathy and lupus nephritis.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative pathway; Complement; Factor H; Glomerular basement membrane; Heparan sulfate

Mesh:

Substances:

Year:  2016        PMID: 27609404      PMCID: PMC5026315          DOI: 10.1016/j.matbio.2016.09.002

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  113 in total

1.  Heparanase mediates cell adhesion independent of its enzymatic activity.

Authors:  Orit Goldshmidt; Eyal Zcharia; Miriam Cohen; Helena Aingorn; Irit Cohen; Liat Nadav; Ben-Zion Katz; Benjamin Geiger; Israel Vlodavsky
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

2.  Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.

Authors:  Una Kelly; Ling Yu; Pallavi Kumar; Jin-Dong Ding; Haixiang Jiang; Gregory S Hageman; Vadim Y Arshavsky; Michael M Frank; Michael A Hauser; Catherine Bowes Rickman
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

Review 3.  Heparin/heparan sulphate interactions with complement--a possible target for reduction of renal function loss?

Authors:  Azadeh Zaferani; Ditmer Talsma; Mareike K S Richter; Mohamed R Daha; Gerjan J Navis; Marc A Seelen; Jacob van den Born
Journal:  Nephrol Dial Transplant       Date:  2013-07-22       Impact factor: 5.992

4.  A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.

Authors:  Vicki Levidiotis; Craig Freeman; Malcolm Punler; Paul Martinello; Brian Creese; Vito Ferro; Johan van der Vlag; Jo H M Berden; Christopher R Parish; David A Power
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

5.  Glomerular endothelial cells and podocytes jointly synthesize laminin-1 and -11 chains.

Authors:  P L St John; D R Abrahamson
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

Review 6.  Glomerular basement membrane composition and the filtration barrier.

Authors:  Jeffrey H Miner
Journal:  Pediatr Nephrol       Date:  2011-02-15       Impact factor: 3.714

7.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

8.  Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.

Authors:  Martin Zenker; Thomas Aigner; Olaf Wendler; Tim Tralau; Horst Müntefering; Regina Fenski; Susanne Pitz; Valérie Schumacher; Brigitte Royer-Pokora; Elke Wühl; Pierre Cochat; Raymonde Bouvier; Cornelia Kraus; Karlheinz Mark; Henry Madlon; Jörg Dötsch; Wolfgang Rascher; Iwona Maruniak-Chudek; Thomas Lennert; Luitgard M Neumann; André Reis
Journal:  Hum Mol Genet       Date:  2004-09-14       Impact factor: 6.150

9.  Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH.

Authors:  D Gilat; R Hershkoviz; I Goldkorn; L Cahalon; G Korner; I Vlodavsky; O Lider
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

Review 10.  Alternative Pathway Dysregulation and the Conundrum of Complement Activation by IgG4 Immune Complexes in Membranous Nephropathy.

Authors:  Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2016-04-25       Impact factor: 7.561

View more
  17 in total

1.  Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold.

Authors:  Roman David Bülow; Peter Boor
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

Review 2.  Complexities of the glomerular basement membrane.

Authors:  Richard W Naylor; Mychel R P T Morais; Rachel Lennon
Journal:  Nat Rev Nephrol       Date:  2020-08-24       Impact factor: 28.314

3.  The potential role of complement alternative pathway activation in hypertensive renal damage.

Authors:  Chongjian Wang; Zhiyu Wang; Wen Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-27

Review 4.  Glycosylation in health and disease.

Authors:  Colin Reily; Tyler J Stewart; Matthew B Renfrow; Jan Novak
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 42.439

5.  Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy.

Authors:  Shuqiang Wang; Yang Lu; Quan Hong; Xiaodong Geng; Xu Wang; Wei Zheng; Chengcheng Song; Chunling Liu; Meng Fan; Yue Xi; Mandi Guo; Di Wu
Journal:  Biomed Res Int       Date:  2017-02-27       Impact factor: 3.411

6.  Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy.

Authors:  Wentian Luo; Florina Olaru; Jeffrey H Miner; Laurence H Beck; Johan van der Vlag; Joshua M Thurman; Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

7.  Differential expression of parietal epithelial cell and podocyte extracellular matrix proteins in focal segmental glomerulosclerosis and diabetic nephropathy.

Authors:  Gek Cher Chan; Diana G Eng; Jeffrey H Miner; Charles E Alpers; Kelly Hudkins; Anthony Chang; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2019-10-21

8.  In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes.

Authors:  Aishwarya Ravindran; Marta Casal Moura; Fernando C Fervenza; Samih H Nasr; Mariam P Alexander; Mary E Fidler; Loren P Herrera Hernandez; Pingchuan Zhang; Joseph P Grande; Lynn D Cornell; Lou Ann Gross; Vivian Negron; Grace E Jenson; Benjamin J Madden; M Cristine Charlesworth; Sanjeev Sethi
Journal:  J Am Soc Nephrol       Date:  2021-01-21       Impact factor: 10.121

Review 9.  Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers.

Authors:  Elizabeth E Hull; McKale R Montgomery; Kathryn J Leyva
Journal:  Int J Mol Sci       Date:  2017-06-26       Impact factor: 5.923

Review 10.  Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis.

Authors:  Cheng-Jie Lin; Zhi-Gao Hu; Guan-Dou Yuan; Biao Lei; Song-Qing He
Journal:  World J Hepatol       Date:  2018-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.